This article is informational coverage of published research literature for Canadian researchers following the broader peptide field
A current GHK-Cu study is testing a topical gel for wound healing, while NAD research spans NAD itself and precursors with route-specific questions
Sikiri P, Petek M, Ruman R, Seiwerth S, et al
Headaches GLP-1-related headaches occur in a subset of users, typically during the first few weeks or after dose escalation
In skincare routines, that translates to something many people want: faster-looking recovery when skin has been through it (dry patches, irritation, rough texture, or the aftermath of a breakout)
GHK-Cus systemic approach means injectable formulations provide benefits beyond the scalp